Tiga Srikandi Jaya is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 2002. Tiga Srikandi Jaya is a prominent player in the Indonesian pharmaceutical industry, focusing on the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company was founded by a group of visionary entrepreneurs with a mission to improve healthcare accessibility and quality in Indonesia. The primary business line of Tiga Srikandi Jaya is the production of generic drugs, which are essential for providing affordable healthcare solutions. The company also engages in secondary activities such as the distribution of medical devices and health supplements. Tiga Srikandi Jaya operates several branches across major cities in Indonesia, ensuring a robust local geographical footprint. The company's product portfolio includes a variety of therapeutic categories, such as antibiotics, analgesics, and cardiovascular drugs. Some of their well-known product brands include SrikandiMed and JayaPharma, which are trusted by healthcare professionals and patients alike. Tiga Srikandi Jaya has established partnerships with several international pharmaceutical companies to enhance its research and development capabilities and expand its product offerings. The company is a member of the Indonesian Pharmaceutical Association, actively participating in industry initiatives and regulatory discussions. With a commitment to innovation and quality, Tiga Srikandi Jaya aims to expand its presence in Southeast Asia and explore export markets in neighboring countries. The company's vision is to become a leading pharmaceutical company in the region, dedicated to improving health outcomes through innovative and accessible healthcare solutions.
Headquarters
Kawasan Bizpark 2 Blok C No 23
East Jakarta; Jakarta;
Postal Code: 13940
Contact Details: Purchase the PT Tiga Srikandi Jaya report to view the information.
Website: http://www.tigasrikandijaya.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service